Page last updated: 2024-10-25

clofibrate and Atypical Lipomatous Tumor

clofibrate has been researched along with Atypical Lipomatous Tumor in 1 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Research Excerpts

ExcerptRelevanceReference
"Clofibrate at lower concentrations (10-200 microM) produced increases in the mRNA levels of cPLA(2) in a dose-response manner."1.31Modulation of cytosolic phospholipase A(2) by PPAR activators in human preadipocytes. ( Choy, PC; Dembinski, T; Hatch, GM; Jiang, YJ; Kroeger, EA; Mymin, D, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, YJ1
Hatch, GM1
Mymin, D1
Dembinski, T1
Kroeger, EA1
Choy, PC1

Other Studies

1 other study available for clofibrate and Atypical Lipomatous Tumor

ArticleYear
Modulation of cytosolic phospholipase A(2) by PPAR activators in human preadipocytes.
    Journal of lipid research, 2001, Volume: 42, Issue:5

    Topics: Acyl-CoA Oxidase; Adipocytes; Arachidonic Acid; Calcimycin; Clofibrate; Cyclooxygenase 2; Enzyme Act

2001